Over dinner, Samira Shamoon's slim, chic friend let her in on a little secret.
She had been dabbling with microdosing – weight loss drugs, but not to drop a few pounds.
'I've been hearing about it for so long,' Samira, 45, exclusively told the Daily Mail. 'It seemed that 2023 was the year of like GLP-1 for weight loss, and 2024 was the news cycle of secondary benefits.'
Read More
Yorumlar
Kalan Karakter: